WoundScribe founder’s AI diabetes care study ranks in top 5% for citation influence

A peer-reviewed study led by WoundScribe AI Founder and CEO Shayan Mashatian has landed in the top 5% of publications for citation influence, according to a provisional NIH-style metric. The paper helped shape WoundScribe’s approach to grounding generative AI in validated clinical knowledge for wound care and diabetic limb preservation.

Why it matters: - The study supports a basic requirement for clinical AI: outputs must be grounded in validated medical knowledge before they can be used at the bedside. - That matters most in diabetic foot care, where faster and more accurate guidance can help prevent avoidable amputations. - The ranking signals that early research on trustworthy generative AI is gaining influence in clinical science.

What happened: - WoundScribe AI said a peer-reviewed study led by Founder and CEO Shayan Mashatian ranks in the top 5% of publications for citation influence. - The ranking is based on the paper’s provisional Relative Citation Ratio, a field-normalized citation metric used by the National Institutes of Health. - The paper, Building Trustworthy Generative Artificial Intelligence for Diabetes Care and Limb Preservation, was published in the Journal of Diabetes Science and Technology. - The research began in late 2023, a few months after GPT-4 became generally available and about a year and a half before advanced reasoning models such as o3 were released.

The details: - The study focused on a central challenge for clinical AI: grounding model outputs in validated clinical knowledge. - The work was among the early papers showing how large language models can be built into trustworthy medical applications. - Mashatian said health systems need AI that can be trusted at the bedside, not just AI that looks strong in a demo. - Mashatian also said the paper’s grounding approach is built into every agent in WoundScribe and aims to let AI co-care with clinicians instead of adding to their workload. - WoundScribe describes its product as a fourth-generation wound care documentation software and clinical decision support platform. - The company says many hospitals still use an EMR plus separate single-function tools, with separate logins and disconnected data. - WoundScribe says its unified AI platform replaces those tools with one wound record and one login. - The platform includes six AI agents inside the clinical workflow: ambient scribe, wound imaging, charting, coding, healing trajectory, and patient education. - The company says the agents can flag whether a wound is healing, stalling, or worsening while there is still time to act. - WoundScribe says its AI-powered wound care free EMR supports unlimited seats. - The company says health systems pay only for on-demand charting, where the AI drafts a chart. - WoundScribe says that pricing model ties costs to patient volume rather than headcount. - WoundScribe AI serves hospitals, health systems and wound care providers. - The company says its platform combines AI wound imaging, ambient scribing, documentation, coding and healing analytics in one record. - WoundScribe says the product is designed by clinicians for clinicians. - WoundScribe directs readers to more information. - The company also listed social channels on LinkedIn, Instagram, YouTube and X.

Between the lines: - The citation ranking gives the research a credibility boost at a time when health systems are still sorting out which AI tools are safe enough for clinical use. - The company is tying a research milestone directly to product design, signaling a strategy of turning published evidence into workflow software. - The free-EMR, unlimited-seat model also suggests WoundScribe is trying to lower the barrier for hospital-wide adoption, especially in wound care teams that need shared access.

What’s next: - WoundScribe is positioning the study as a foundation for continued product development around clinical trust, bedside use and wound-care workflow integration. - The company is likely to keep promoting the research-to-product link as hospitals evaluate AI tools that can document, code and support treatment decisions in one system. - The ranking may also help the paper and WoundScribe’s platform stand out as more health systems look for evidence-backed AI vendors.